Notice of Q1 Results

RNS Number : 8935P

Benchmark Holdings PLC

14 February 2023

 

14 February 2023

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

Notice of Q1 Results

Presentation for analysts and institutional investors

Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture biotechnology business, will announce its Q1 results, for the three month period ended 31 December 2022, on Tuesday 28 February 2023. 

Presentation for analysts and investors at 9 am CET

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host an in-person presentation for analysts and institutional investors on the day at 9.00 am CET/8.00 am UK time in Oslo, Norway. The presentation will take place at Hotel Continental, Stortingsgata 24/26, 0117 Oslo.

A live webcast of the presentation is available for analysts and investors to join remotely at the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230228_7  

For further details, and to register your interest, please contact  [e-mail] .

Equity Development webcast on Wednesday 1 March at 12 pm UK time

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a second webcast for retail investors and wealth managers on Wednesday 1 March at 13.00 pm CET/12.00 pm UK time. The webcast is open to all existing and potential shareholders.

To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1results-presentation-1march2023

A recording of the presentation will be available after the event on the Equity Development website .

  Enquiries

For further information, please contact: Benchmark Holdings plc Tel:  [phone] Trond Williksen, CEO Septima Maguire, CFO Ivonne Cantu, Investor Relations Numis (Broker and NOMAD) Tel:  [phone] James Black, Freddie Barnfield, Duncan Monteith MHP Tel:  [phone] Katie Hunt, Reg Hoare, Veronica Farah [e-mail] Equity Development Hannah Crowe Tel:  [phone]

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com .

 

END

 

 

NORGPUCWPUPWGGC